We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
+8.27%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.6B
AUM Growth
+$769M
Cap. Flow
+$469M
Cap. Flow %
8.38%
Top 10 Hldgs %
13.16%
Holding
1,266
New
125
Increased
352
Reduced
429
Closed
264

Sector Composition

Rank Sector Weight
1 Technology 19.55%
2 Financials 15.15%
3 Healthcare 14.96%
4 Consumer Discretionary 10.52%
5 Industrials 10.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VAR
801
DELISTED
Varian Medical Systems, Inc.
VAR
$318K 0.01%
3,638
+559
+18% +$45.6K
RT
802
DELISTED
Ruby Tuesday Georgia
RT
$317K 0.01%
126,979
+35,043
+38% +$117K
PKOH icon
803
Park-Ohio Holdings
PKOH
$554M
$313K 0.01%
8,590
-240
-3% -$7.99K
CDMO
804
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$313K 0.01%
103,886
-17,000
-14% -$45.7K
WTW icon
805
Willis Towers Watson
WTW
$27.9B
$312K 0.01%
+2,350
New +$293K
VOXX
806
DELISTED
VOXX International Corporation Class A
VOXX
$310K 0.01%
103,683
WSFS icon
807
WSFS Financial
WSFS
$4.1B
$309K 0.01%
8,465
-300
-3% -$10.8K
MRIN
808
DELISTED
Marin Software
MRIN
$308K 0.01%
2,914
-789
-21% -$82.4K
EFOR
809
Everforth Inc
EFOR
$845M
$298K 0.01%
+8,210
New +$305K
TRCO
810
DELISTED
TRIBUNE MEDIA COMPANY CLASS A
TRCO
$298K 0.01%
8,150
-102,490
-93% -$3.89M
AEE icon
811
Ameren
AEE
$31.5B
$296K 0.01%
6,010
-1,560
-21% -$79.6K
RXDX
812
DELISTED
Ignyta, Inc.
RXDX
$296K 0.01%
47,048
-9,700
-17% -$56.3K
TBNK
813
DELISTED
Territorial Bancorp Inc.
TBNK
$295K 0.01%
10,300
-100
-1% -$2.79K
ASMB icon
814
Assembly Biosciences
ASMB
$506M
$294K 0.01%
3,397
-568
-14% -$43.9K
KRA
815
DELISTED
Kraton Corporation
KRA
$292K 0.01%
8,340
-50,267
-86% -$1.61M
FMC icon
816
FMC
FMC
$1.42B
$291K 0.01%
6,930
-33,206
-83% -$1.37M
CLAR icon
817
Clarus
CLAR
$125M
$290K 0.01%
56,651
-5,323
-9% -$24.3K
RPD icon
818
Rapid7
RPD
$634M
$290K 0.01%
16,427
-15,773
-49% -$247K
GTS
819
DELISTED
Triple-S Management Corporation
GTS
$290K 0.01%
13,921
-10,406
-43% -$233K
PAMT
820
PAMT Corp
PAMT
$340M
$286K 0.01%
57,196
-400
-0.7% -$1.91K
USAK
821
DELISTED
USA Truck Inc
USAK
$286K 0.01%
27,884
+2,420
+10% +$34.3K
PRTS icon
822
CarParts.com
PRTS
$42.8M
$285K 0.01%
8,670
+2,170
+33% +$82.6K
GUID
823
DELISTED
Guidance Software, Inc.
GUID
$280K 0.01%
46,931
-16,382
-26% -$97.2K
HALL
824
DELISTED
Hallmark Financial Services, Inc.
HALL
$278K 0.01%
2,704
-1,149
-30% -$123K
QADA
825
DELISTED
QAD Inc.
QADA
$277K ﹤0.01%
12,399
+1,000
+9% +$20.6K

Similar funds

Jacobs Levy Equity Management's Q3 2016 Portfolio in Review

As of Q3 2016, Jacobs Levy Equity Management held 1,266 positions worth $5.6B, up 16% from $4.83B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Jacobs Levy Equity Management deployed $469M of net new capital in Q3 2016, opening 125 new positions and adding to 352 existing holdings. Its largest new stake was Bristol-Myers Squibb: 916,932 shares worth $49.4M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Intercontinental Exchange, an estimated $26M trimmed.

  • Jacobs Levy Equity Management's largest Q3 2016 buy was Bristol-Myers Squibb: 916,932 shares worth $49.4M.
  • Jacobs Levy Equity Management added most to Agilent Technologies in Q3 2016, an estimated $25.5M increase.
  • Jacobs Levy Equity Management's biggest Q3 2016 reduction was Intercontinental Exchange, cutting an estimated $26M.
  • Jacobs Levy Equity Management fully exited Gen Digital in Q3 2016, selling an estimated $27.1M.
  • Jacobs Levy Equity Management's ten largest holdings make up 13% of its $5.6B portfolio in Q3 2016.
  • Jacobs Levy Equity Management opened 125 new positions and closed 264 in Q3 2016.
  • Jacobs Levy Equity Management's portfolio value rose 16% quarter-over-quarter to $5.6B.

Based on Jacobs Levy Equity Management's 13F filing for Q3 2016, filed 14 Nov 2016.